|
VAPB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.016800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.824800E-04 |
| Normal-vs-Stage2 |
5.204200E-01 |
| Normal-vs-Stage3 |
2.353000E-01 |
| Normal-vs-Stage4 |
1.620690E-04 |
| Stage1-vs-Stage2 |
3.265200E-01 |
| Stage1-vs-Stage3 |
4.811600E-01 |
| Stage1-vs-Stage4 |
2.066800E-01 |
| Stage2-vs-Stage3 |
7.796000E-01 |
| Stage2-vs-Stage4 |
1.391570E-01 |
| Stage3-vs-Stage4 |
1.630410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.143000E-03 |
| Normal-vs-AfricanAmerican |
1.602570E-04 |
| Normal-vs-Asian |
1.319850E-01 |
| Caucasian-vs-AfricanAmerican |
1.862830E-01 |
| Caucasian-vs-Asian |
5.057200E-01 |
| AfricanAmerican-vs-Asian |
6.602400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.419390E-04 |
| Normal-vs-Female |
1.725240E-01 |
| Male-vs-Female |
1.126160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.245100E-04 |
| Normal-vs-Extreme_Weight |
4.16290000004871E-06 |
| Normal-vs-Obese |
1.604400E-01 |
| Normal-vs-Extreme_Obese |
8.580200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.482200E-01 |
| Normal_Weight-vs-Obese |
8.200400E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.387900E-02 |
| Extreme_Weight-vs-Obese |
2.561900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.350300E-02 |
| Obese-vs-Extreme_Obese |
6.392600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.583000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.257170E-01 |
| Normal-vs-Age(61-80Yrs) |
5.66490000000197E-05 |
| Normal-vs-Age(81-100Yrs) |
5.402600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.351000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.365400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.221700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.822500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.911600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.697000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.425800E-04 |
| Normal-VS-Type2 PRCC |
3.304400E-03 |
| Normal-VS-KIRP CIMP |
1.556360E-01 |
| Normal-VS-Unclassified PRCC |
5.889200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.092400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.875600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.045800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.470000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.302100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.391610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.023900E-03 |
| Normal-vs-N1 |
1.613590E-02 |
| Normal-vs-N2 |
2.788400E-01 |
| N0-vs-N1 |
5.295000E-01 |
| N0-vs-N2 |
8.418600E-01 |
| N1-vs-N2 |
5.205600E-01 |
|
|
